| Not Yet Recruiting | A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Lichen Sclerosus | Phase 3 | 2026-05-06 |
| Recruiting | A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants Wit Palmoplantar Pustulosis | Phase 2 | 2025-09-11 |
| Completed | A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of Joint Pain, Gout Flares, Joint Inflammation | Phase 1 | 2024-12-06 |
| Recruiting | A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Chi Atopic Dermatitis | Phase 3 | 2024-06-10 |
| Completed | A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis | Phase 2 | 2023-09-20 |
| Completed | A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolesc Chronic Hand Eczema | Phase 3 | 2023-09-05 |
| Completed | A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Atopic Dermatitis, Atopic Hand Eczema | Phase 3 | 2023-08-28 |
| Completed | A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Su Stable Plaque Psoriasis | Phase 3 | 2023-06-21 |
| Completed | Investigating the Safety of LEO 158968 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2023-02-07 |
| Terminated | Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Pso Psoriasis | Phase 3 | 2022-12-07 |
| Active Not Recruiting | Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDi Atopic Dermatitis | Phase 2 | 2022-09-07 |
| Completed | Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema Chronic Hand Eczema | Phase 1 | 2022-09-06 |
| Completed | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Pso Psoriasis Vulgaris | Phase 4 | 2022-08-16 |
| Completed | Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Ha Chronic Hand Eczema | Phase 3 | 2022-07-14 |
| Completed | A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Chronic Hand Eczema | Phase 3 | 2022-06-15 |
| Completed | A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD Atopic Dermatitis | Phase 2 | 2022-05-19 |
| Completed | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Frontal Fibrosing Alopecia | Phase 2 | 2022-04-19 |
| Completed | Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Atopic Dermatitis | Phase 3 | 2022-01-13 |
| Completed | A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japane Atopic Dermatitis | Phase 1 | 2021-11-03 |
| Completed | A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People Healthy Volunteers | EARLY_Phase 1 | 2021-09-29 |
| Completed | Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials Chronic Hand Eczema | Phase 3 | 2021-08-23 |
| Completed | An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. Atopic Dermatitis | Phase 2 | 2021-07-14 |
| Completed | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) Chronic Hand Eczema | Phase 3 | 2021-05-25 |
| Completed | A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults Healthy Volunteers | Phase 1 | 2021-05-17 |
| Completed | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema Chronic Hand Eczema | Phase 3 | 2021-05-10 |
| Completed | Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream Healthy Volunteers | Phase 1 | 2021-03-25 |
| Completed | A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects Healthy | Phase 1 | 2021-02-08 |
| Terminated | Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequa Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis | Phase 4 | 2020-12-17 |
| Completed | Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic D Atopic Dermatitis | Phase 3 | 2020-10-27 |
| Completed | Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream Healthy Volunteers | Phase 1 | 2020-04-23 |
| Terminated | Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. Discoid Lupus Erythematosus | Phase 2 | 2019-07-09 |
| Withdrawn | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy | Phase 1 | 2019-07-03 |
| Completed | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Di Psoriasis Vulgaris | Phase 1 | 2019-04-15 |
| Completed | Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolesc Atopic Dermatitis | Phase 1 | 2019-02-20 |
| Completed | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris Psoriasis Vulgaris | Phase 3 | 2019-01-24 |
| Completed | A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of L Healthy | Phase 1 | 2019-01-22 |
| Withdrawn | Investigation of Flare and Remission in Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 4 | 2019-01-14 |
| Completed | Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Atopic Dermatitis | Phase 2 | 2018-12-28 |
| Completed | Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 Atopic Dermatitis | Phase 3 | 2018-12-13 |
| Completed | Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Chronic Hand Eczema | Phase 2 | 2018-11-28 |
| Completed | Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin Healthy | Phase 1 | 2018-11-22 |
| Completed | A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development | — | 2018-11-16 |
| Completed | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a Psoriasis Vulgaris | Phase 1 | 2018-09-27 |
| Completed | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 Atopic Dermatitis | Phase 1 | 2018-08-13 |
| Terminated | Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Infected Atopic Dermatitis/Eczema | Phase 3 | 2018-07-31 |
| Completed | Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) Atopic Dermatitis | Phase 2 | 2018-07-13 |
| Completed | Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema Atopic Dermatitis | Phase 3 | 2018-06-19 |
| Completed | Body PSOriasis: Long-term Relapse CONTROL Psoriasis Vulgaris | — | 2018-06-11 |
| Completed | Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2018-05-07 |
| Completed | Dermatopharmacokinetic Trial of LEO 90100 Foam Healthy | Phase 1 | 2018-03-20 |
| Completed | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials Atopic Dermatitis | Phase 3 | 2018-03-18 |
| Completed | Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 Atopic Dermatitis | Phase 3 | 2018-02-22 |
| Completed | Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese S Psoriasis Vulgaris | Phase 1 | 2018-01-30 |
| Completed | A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Aci Psoriasis Vulgaris | Phase 4 | 2017-11-03 |
| Terminated | Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. Alopecia Areata | Phase 2 | 2017-10-30 |
| Completed | Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Psoriasis Vulgaris | Phase 1 | 2017-07-25 |
| Completed | A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea Rosacea | — | 2017-07-20 |
| Completed | Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Followi Skin Inflammation | N/A | 2017-06-19 |
| Terminated | A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treat Actinic Keratosis, Squamous Cell Carcinoma | Phase 3 | 2017-06-16 |
| Completed | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) Atopic Dermatitis | Phase 3 | 2017-06-12 |
| Completed | Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 a Drug Interaction Potentiation | Phase 1 | 2017-05-31 |
| Completed | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) Atopic Dermatitis | Phase 3 | 2017-05-30 |
| Completed | LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris Psoriasis Vulgaris | Phase 3 | 2017-02-15 |
| Completed | PSOREAL - Managing PSOriasis in the REAL World Psoriasis Vulgaris | — | 2017-01-01 |
| Completed | Vasoconstriction Trial With LEO 90100 Aerosol Foam Psoriasis Vulgaris | Phase 1 | 2016-12-01 |
| Completed | Efficacy and Tolerability of Enstilar® in Daily Practice Plaque Psoriasis | — | 2016-09-01 |
| Completed | LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2016-09-01 |
| Completed | Biological Effects of LEO 43204 in Actinic Keratosis Actinic Keratosis | Phase 1 | 2016-07-01 |
| Completed | Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne Acne Vulgaris | Phase 2 | 2016-06-01 |
| Completed | Real-life Evaluation of the Daivobet® Gel Applicator Plaque Psoriasis | — | 2016-05-23 |
| Terminated | A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects Psoriasis Vulgaris | Phase 1 | 2016-04-01 |
| Completed | Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasi Inverse Psoriasis | Phase 2 | 2016-03-01 |
| Completed | Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Pl Psoriasis Vulgaris | Phase 2 | 2016-03-01 |
| Completed | LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis Psoriasis Vulgaris | Phase 3 | 2016-02-01 |
| Completed | A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel Actinic Keratosis | Phase 1 | 2016-02-01 |
| Completed | Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema Hand Eczema | Phase 2 | 2016-02-01 |
| Completed | LEO 124249 Ointment in the Treatment of Alopecia Areata Alopecia Areata | Phase 2 | 2016-01-01 |
| Completed | Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study Psoriasis Vulgaris | — | 2016-01-01 |
| Completed | An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switche Dermatitis, Atopic | — | 2015-12-10 |
| Completed | The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice Actinic Keratosis | — | 2015-12-01 |
| Completed | Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-mont Actinic Keratosis | Phase 3 | 2015-11-13 |
| Completed | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month F Actinic Keratosis | Phase 3 | 2015-11-01 |
| Completed | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month F Actinic Keratosis | Phase 3 | 2015-11-01 |
| Completed | Dermatopharmacokinetic Trial of LEO 80185 Gel Psoriasis Vulgaris | Phase 1 | 2015-11-01 |
| Completed | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month F Actinic Keratosis | Phase 3 | 2015-11-01 |
| Completed | An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A Psoriasis Vulgaris | Phase 1 | 2015-11-01 |
| Completed | Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population Psoriasis Vulgaris | Phase 4 | 2015-09-01 |
| Completed | A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris Skin and Connective Tissue Diseases | Phase 2 | 2015-08-01 |
| Completed | An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatiti Atopic Dermatitis | Phase 1 | 2015-07-01 |
| Completed | LEO 32731 - A Phase I Study in Healthy Subjects Psoriasis Vulgaris | Phase 1 | 2015-07-01 |
| Completed | Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions Actinic Keratosis | Phase 1 | 2015-05-01 |
| Completed | Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism Venous Thromboembolism | — | 2015-05-01 |
| Completed | Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Ches Actinic Keratosis | Phase 3 | 2015-04-01 |
| Completed | Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actin Actinic Keratosis (AK) | Phase 4 | 2015-04-01 |
| Completed | A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) Skin and Connective Tissue Diseases | Phase 2 | 2015-04-01 |
| Completed | A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin Tissue Diseases, Connective Tissue Diseases | Phase 1 | 2015-03-01 |
| Completed | Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively Actinic Keratosis | Phase 2 | 2015-03-01 |
| Completed | Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects Skin and Connective Tissue Diseases | Phase 1 | 2015-03-01 |
| Completed | Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts Anogenital Warts | Phase 2 | 2015-02-01 |
| Completed | A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) Atopic Dermatitis | Phase 1 | 2015-02-01 |
| Completed | Preferences & Treatment Satisfaction Drivers in Rosacea Patients Rosacea | — | 2015-01-08 |
| Completed | Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris Psoriasis Vulgaris | Phase 3 | 2015-01-01 |
| Completed | A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin Skin and Connective Tissue Diseases | Phase 1 | 2015-01-01 |
| Completed | PMS to Evaluate the Safety and Efficacy of Picato® Gel Actinic Keratosis | — | 2014-09-01 |
| Completed | The Real Life Topical Field Treatment of Actinic Keratosis Study Actinic Keratosis | — | 2014-07-01 |
| Completed | Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) Atopic Dermatitis | Phase 1 | 2014-07-01 |
| Completed | LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Psoriasis Vulgaris | Phase 3 | 2014-06-01 |
| Completed | Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subject Actinic Keratosis | Phase 1 / Phase 2 | 2014-05-01 |
| Completed | Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximat Actinic Keratosis | Phase 1 / Phase 2 | 2014-05-01 |
| Completed | LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects Psoriasis Vulgaris | Phase 1 | 2014-05-01 |
| Completed | Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions Actinic Keratosis | Phase 1 | 2014-04-01 |
| Completed | A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatiti Atopic Dermatitis | Phase 1 | 2014-04-01 |
| Completed | TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl M Actinic Keratosis | — | 2014-04-01 |
| Completed | An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Su Psoriasis Vulgaris | Phase 2 | 2014-01-01 |
| Completed | Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Actinic Keratosis | Phase 2 | 2014-01-01 |
| Completed | Topical Aprepitant in Prurigo Patients Pruritus | Phase 2 | 2013-10-01 |
| Completed | A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Actinic Keratosis | Phase 1 / Phase 2 | 2013-10-01 |
| Completed | Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5 Actinic Keratosis (AK) | Phase 4 | 2013-09-11 |
| Completed | A Vasoconstriction Study With LEO 90100 Psoriasis Vulgaris | Phase 1 | 2013-09-01 |
| Completed | Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100 Psoriasis Vulgaris | Phase 1 | 2013-08-01 |
| Completed | An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethason Psoriasis Vulgaris | — | 2013-07-01 |
| Completed | Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Inge Actinic Keratosis | — | 2013-07-01 |
| Completed | Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Actinic Keratosis | Phase 1 | 2013-07-01 |
| Completed | LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris Psoriasis Vulgaris | Phase 3 | 2013-06-01 |
| Completed | Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO Atopic Dermatitis | Phase 1 | 2013-05-01 |
| Completed | An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Psoriasis Vulgaris | Phase 1 | 2013-04-01 |
| Completed | Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Kerato Actinic Keratosis | Phase 1 / Phase 2 | 2013-04-01 |
| Completed | Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratos Actinic Keratosis | Phase 1 / Phase 2 | 2013-02-01 |
| Completed | A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% a Actinic Keratosis | Phase 3 | 2013-02-01 |
| Completed | Cromoglicate in Psoriasis Psoriasis | Phase 2 | 2012-11-01 |
| Completed | Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis | Phase 1 | 2012-11-01 |
| Completed | Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatm Venous Thromboembolism | — | 2012-11-01 |
| Completed | Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formu Psoriasis Vulgaris, Plaque Psoriasis | — | 2012-10-01 |
| Terminated | Cromoglicate in Mastocytosis Mastocytosis | Phase 2 | 2012-10-01 |
| Completed | Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea Papulopustular Rosacea | Phase 3 | 2012-09-01 |
| Completed | The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects Psoriasis Vulgaris | Phase 1 / Phase 2 | 2012-07-01 |
| Completed | A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2012-06-01 |
| Completed | LEO 90100 in the Treatment of Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2012-05-01 |
| Completed | Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtens Psoriasis Vulgaris | Phase 2 | 2012-05-01 |
| Completed | Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp Actinic Keratosis | Phase 3 | 2012-05-01 |
| Completed | LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Psoriasis Vulgaris | Phase 2 | 2012-05-01 |
| Completed | A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris Psoriasis Vulgaris | Phase 1 | 2012-04-01 |
| Completed | A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face a Actinic Keratosis | Phase 3 | 2012-03-01 |
| Completed | Study on Thrombosis Therapy in German Cancer Patients Cancer, Deep Vein Thrombosis, Pulmonary Embolism | — | 2012-02-01 |
| Completed | An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris Psoriasis Vulgaris | Phase 1 | 2011-11-01 |
| Completed | Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vul Acne Vulgaris | Phase 2 | 2011-11-01 |
| Completed | 21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation Healthy | Phase 1 | 2011-09-01 |
| Completed | Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation Healthy | Phase 1 | 2011-09-01 |
| Completed | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy Actinic Keratosis | Phase 1 | 2011-09-01 |
| Terminated | Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. Atopic Dermatitis | Phase 1 | 2011-09-01 |
| Completed | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology Actinic Keratosis | Phase 1 | 2011-08-01 |
| Completed | Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 Atopic Dermatitis | Phase 1 | 2011-08-01 |
| Completed | LEO 90105 Ointment in Japanese Subjects With Psoriasis Psoriasis | Phase 3 | 2011-07-01 |
| Completed | A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2011-05-01 |
| Completed | Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris Psoriasis Vulgaris | — | 2011-04-01 |
| Completed | A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of He Healthy | Phase 1 | 2011-03-01 |
| Completed | LEO 32731 - A Study in Healthy Male Subjects Healthy Subjects | Phase 1 | 2011-03-01 |
| Completed | A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoria Psoriasis Vulgaris | Phase 1 | 2011-02-01 |
| Completed | Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea Papulopustular Rosacea | Phase 1 | 2011-01-01 |
| Completed | A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin Healthy | Phase 1 | 2010-12-01 |
| Completed | Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2010-10-01 |
| Completed | Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis Scalp Psoriasis | Phase 3 | 2010-09-01 |
| Completed | LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects Healthy | Phase 1 | 2010-09-01 |
| Completed | LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Psoriasis Vulgaris | Phase 3 | 2010-09-01 |
| Completed | Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembol Venous Thromboembolism | Phase 3 | 2010-08-01 |
| Completed | LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects Healthy | Phase 1 | 2010-06-01 |
| Completed | LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism P Secondary Hyperparathyroidism | Phase 1 | 2010-06-01 |
| Completed | The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847 Renal Impairment | Phase 1 | 2010-05-01 |
| Completed | Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis Scalp Psoriasis | Phase 2 | 2010-05-01 |
| Completed | A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution f Psoriasis Vulgaris | Phase 2 | 2010-05-01 |
| Completed | Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasi Scalp Psoriasis | Phase 2 | 2010-04-01 |
| Completed | A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Pso Psoriasis Vulgaris | Phase 1 | 2010-04-01 |
| Completed | An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects Irritation | Phase 1 | 2010-04-01 |
| Completed | A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris Psoriasis Vulgaris | Phase 1 | 2010-01-01 |
| Completed | Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel) Scalp Psoriasis | — | 2010-01-01 |
| Completed | Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea Papulopustular Rosacea | Phase 2 | 2009-12-01 |
| Completed | LEO 29102 Cream in the Treatment of Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2009-12-01 |
| Completed | A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris | Phase 3 | 2009-10-01 |
| Completed | A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2009-10-01 |
| Completed | Assessment of the Phototoxic Potential of LEO 29102 Cream Atopic Dermatitis | Phase 1 | 2009-09-01 |
| Completed | LEO 27847 - A Study in Healthy Male Subjects Healthy | Phase 1 | 2009-09-01 |
| Completed | Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2009-07-01 |
| Completed | A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products Psoriasis Vulgaris | Phase 2 | 2009-04-01 |
| Completed | LEO 29102 Single and Multiple Dose Study by Dermal Application Atopic Dermatitis | Phase 1 | 2009-03-01 |
| Completed | Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lena Multiple Myeloma | — | 2009-02-01 |
| Completed | Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Papulopustular Rosacea | Phase 4 | 2009-02-01 |
| Completed | A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2009-01-01 |
| Completed | LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjec Psoriasis Vulgaris | Phase 1 | 2009-01-01 |
| Completed | The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impeti Secondarily Infected Traumatic Lesions (SITL), Impetigo | Phase 2 | 2008-12-01 |
| Completed | Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2008-09-01 |
| Completed | Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses Skin Mycoses | — | 2008-07-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Fo Psoriasis Vulgaris | Phase 3 | 2008-05-01 |
| Completed | Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in P Psoriasis Vulgaris | Phase 2 | 2008-05-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and Psoriasis Vulgaris | Phase 3 | 2008-04-01 |
| Completed | Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions ( Impetigo, Secondarily Infected Traumatic Lesions | Phase 2 | 2008-02-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients Psoriasis Vulgaris | Phase 3 | 2008-02-01 |
| Completed | Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea Papulopustular Rosacea | Phase 2 | 2008-01-01 |
| Terminated | Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis Disseminated Intravascular Coagulation | Phase 2 | 2007-07-01 |
| Completed | A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily Papulopustular Rosacea | Phase 4 | 2007-01-01 |
| Completed | A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face Seborrheic Dermatitis on the Face | Phase 2 | 2006-12-01 |
| Completed | A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis Perioral Dermatitis | Phase 2 | 2006-11-01 |
| Completed | LEO19123 Cream in the Treatment of Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2006-10-01 |
| Completed | LEO19123 Cream in the Treatment of Hand Eczema Hand Eczema | Phase 2 | 2006-10-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris Psoriasis Vulgaris | Phase 2 | 2005-12-01 |
| Completed | Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis Deep Vein Thrombosis | Phase 4 | 2005-12-01 |
| Completed | Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis Psoriasis | Phase 3 | 2005-12-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgar Psoriasis Vulgaris | Phase 4 | 2005-10-01 |
| Completed | Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis Psoriasis of Scalp | Phase 3 | 2005-09-01 |
| Terminated | A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Der Atopic Dermatitis | — | 2005-05-25 |
| Completed | Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasi Psoriasis Vulgaris | Phase 4 | 2005-04-01 |
| Completed | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis Dermatitis, Atopic | Phase 4 | 2005-03-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis Psoriasis of Scalp | Phase 3 | 2005-02-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis Psoriasis of Scalp | Phase 3 | 2004-12-01 |
| Completed | Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis Psoriasis of Scalp | Phase 3 | 2004-11-01 |
| Terminated | Fucidin® Cream in the Treatment of Impetigo Impetigo | Phase 4 | 2004-05-01 |
| Terminated | Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 3 | 2003-01-01 |
| Completed | Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate A Acne Vulgaris | Phase 3 | 2002-01-01 |
| Terminated | Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma Liver Neoplasms | Phase 3 | 1999-11-01 |
| Terminated | Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma Liver Neoplasms | N/A | 1999-09-01 |